NL257275A
(hu)
|
1959-10-26 |
|
|
|
US3261761A
(en)
|
1962-05-07 |
1966-07-19 |
Arthur W Anderson |
Method of freeze drying bacterial cultures
|
WO1984004037A1
(en)
|
1983-04-13 |
1984-10-25 |
Field Group Res Pty Ltd |
Enema bag
|
WO1989003219A1
(en)
|
1987-10-12 |
1989-04-20 |
Borody Thomas J |
Improved method for treatment of gastrointestinal disorders
|
DE3744745A1
(de)
|
1987-12-04 |
1989-06-15 |
Claus Dr Med Jansen |
Elektroakustischer wandler
|
EP0397689B1
(en)
|
1987-12-24 |
1994-05-11 |
BORODY, Thomas Julius |
Orthostatic lavage solutions
|
US5443826A
(en)
*
|
1988-08-02 |
1995-08-22 |
Borody; Thomas J. |
Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli
|
WO1990001335A1
(en)
|
1988-08-02 |
1990-02-22 |
Borody Thomas J |
Treatment of gastro-intestinal disorders
|
CA1337265C
(en)
|
1988-08-04 |
1995-10-10 |
Thomas Julius Borody |
Oral antibody therapy for patients with lowered immune response and composition therefor
|
CA2051092C
(en)
|
1990-09-12 |
2002-07-23 |
Stephen A. Livesey |
Method and apparatus for cryopreparation, dry stabilization and rehydration of biological suspensions
|
ES2213139T5
(es)
|
1990-10-22 |
2011-03-18 |
Centre For Digestive Diseases Pty Ltd |
Tratamiento de trastornos intestinales no inflamatorios.
|
US5519014A
(en)
|
1990-10-22 |
1996-05-21 |
Borody; Thomas J. |
Treatment of non-inflammatory and non-infectious bowel disorders
|
US5229374A
(en)
|
1992-01-28 |
1993-07-20 |
Burton Albert F |
Method for treatment of lower gastrointestinal tract disorders
|
US5599795A
(en)
|
1994-08-19 |
1997-02-04 |
Mccann; Michael |
Method for treatment of idiopathic inflammatory bowel disease (IIBD)
|
AUPM864894A0
(en)
|
1994-10-07 |
1994-11-03 |
Borody, Thomas Julius |
Treatment of bowel-dependent neurological disorders
|
US6861053B1
(en)
|
1999-08-11 |
2005-03-01 |
Cedars-Sinai Medical Center |
Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
|
US7048906B2
(en)
|
1995-05-17 |
2006-05-23 |
Cedars-Sinai Medical Center |
Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
|
US5656283A
(en)
|
1995-06-08 |
1997-08-12 |
Ortho Pharmaceutical Corporation |
In-situ lyophilization of vaginal suppository in unit dose applicator and resultant product
|
ATE310391T1
(de)
|
1995-09-15 |
2005-12-15 |
Dale N Gerding |
Verfahren und zusammensetzung zur vorbeugung und behandlung von mit clostridium difficile assoziierten erkrankungen
|
AUPN634595A0
(en)
|
1995-11-03 |
1995-11-30 |
Borody, Thomas Julius |
Improved method for colonic evacuation
|
US6103268A
(en)
|
1995-11-03 |
2000-08-15 |
Borody; Thomas Julius |
Administering osmotic colonic evacuant containing a picosulfate
|
US5925354A
(en)
|
1995-11-30 |
1999-07-20 |
Michigan State University |
Riboflavin mutants as vaccines against Actinobacillus pleuropneumoniae
|
US5711446A
(en)
*
|
1996-01-16 |
1998-01-27 |
Sorenson Bioscience, Inc. |
Cryogenic freezing vial
|
US5902578A
(en)
|
1996-03-25 |
1999-05-11 |
Abbott Laboratories |
Method and formula for the prevention of diarrhea
|
US5837238A
(en)
|
1996-06-05 |
1998-11-17 |
Biogaia Biologics Ab |
Treatment of diarrhea
|
US6096310A
(en)
|
1997-04-15 |
2000-08-01 |
Bier; Milan |
Oral immunotherapy of bacterial overgrowth
|
AUPO665397A0
(en)
|
1997-05-07 |
1997-05-29 |
Borody, Thomas Julius |
Novel therapy for constipation
|
US6969520B2
(en)
|
1997-10-20 |
2005-11-29 |
Acambis Inc. |
Active immunization against clostridium difficile disease
|
CA2307331C
(en)
|
1997-10-20 |
2017-03-21 |
Oravax, Inc. |
Passive immunization against clostridium difficile disease
|
US6428783B1
(en)
|
1998-03-11 |
2002-08-06 |
Medtech Center, Inc. |
Bank of autochthonous strains of microorganisms and methods of its use for recovery of intestinal microbiocenosis of the men
|
US6461607B1
(en)
|
1998-08-24 |
2002-10-08 |
Ganeden Biotech, Inc. |
Probiotic, lactic acid-producing bacteria and uses thereof
|
WO2000016619A1
(en)
|
1998-09-21 |
2000-03-30 |
21St Century Medicine, Inc. |
Polyvinyl alcohol compounds for inhibition of ice growth
|
ID29150A
(id)
*
|
1999-01-15 |
2001-08-02 |
Entpr Ireland Cs |
Penggunaan lactobacillus salivarius
|
US7430478B2
(en)
*
|
2000-03-01 |
2008-09-30 |
Caridian Bct, Inc. |
Blood processing information system with blood loss equivalency tracking
|
FR2808689B1
(fr)
|
2000-05-11 |
2004-09-03 |
Agronomique Inst Nat Rech |
Utilisation de souches acetogenes hydrogenotrophes pour la prevention ou le traitement de troubles digestifs
|
JP2001327280A
(ja)
|
2000-05-23 |
2001-11-27 |
Lion Corp |
菌用凍結保存液
|
US20020013270A1
(en)
|
2000-06-05 |
2002-01-31 |
Bolte Ellen R. |
Method for treating a mental disorder
|
US20040170617A1
(en)
|
2000-06-05 |
2004-09-02 |
Finegold Sydney M. |
Method of treating diseases associated with abnormal gastrointestinal flora
|
US20040062757A1
(en)
|
2001-06-05 |
2004-04-01 |
Finegold Sydney M. |
Method of testing gastrointestinal diseases associated with species of genus clostridium
|
EP1296693A4
(en)
|
2000-06-19 |
2005-05-25 |
Mucoprotec Pty Ltd |
IMMUNOTHERAPY AND PROBIOTIC COMPOUNDS FOR THE TREATMENT OF BACTERIAL OR VIRAL INFECTIONS ON MUCOSAL SURFACES
|
CA2416120A1
(en)
|
2000-07-17 |
2002-01-24 |
Svend Laulund |
Methods and formulations with probiotic microorganisms and medicaments
|
AUPQ899700A0
(en)
|
2000-07-25 |
2000-08-17 |
Borody, Thomas Julius |
Probiotic recolonisation therapy
|
CA2427898C
(en)
|
2000-11-14 |
2017-08-15 |
Techlab, Inc. |
Method for differentiating between irritable bowel syndrome and inflammatory bowel disease using lactoferrin as marker
|
CA2436574A1
(en)
|
2000-12-06 |
2002-06-13 |
Pharmacia Corporation |
Laboratory scale milling process
|
MEP32608A
(en)
|
2001-06-26 |
2011-02-10 |
Amgen Fremont Inc |
Antibodies to opgl
|
AU2002365913A1
(en)
|
2001-09-06 |
2003-09-16 |
Genomic Profiling Systems, Inc. |
Rapid and sensitive detection of cells and viruses
|
EP1300472A1
(en)
|
2001-10-02 |
2003-04-09 |
Stichting Top-Instituut Voedselwetenschappen |
A method for testing the effect of nutrients on gastrointestinal colonisation resistance of humans
|
GB0124580D0
(en)
|
2001-10-12 |
2001-12-05 |
Univ Reading |
New composition
|
EP1448987A4
(en)
*
|
2001-12-10 |
2005-06-08 |
Ardais Corp |
SYSTEM AND METHODS FOR OBTAINING PATIENT SAMPLES IN CORRELATION WITH DATA
|
US20030161871A1
(en)
|
2001-12-19 |
2003-08-28 |
Geoffrey Hird |
Solubilized riboflavin
|
AUPS088702A0
(en)
|
2002-03-04 |
2002-03-28 |
Borody, Thomas Julius |
Electrolyte purgative
|
AU2003225973A1
(en)
|
2002-03-26 |
2003-11-11 |
Glaxo Group Limited |
A method for forming a laminate assembly and products formed thereby
|
EP1596872B1
(en)
|
2003-01-24 |
2011-06-22 |
Flora Technology Inc. |
Compositions and methods for restoring bacterial flora
|
GB0322791D0
(en)
|
2003-09-30 |
2003-10-29 |
Lifeforce Group Plc |
Blood co-processing for contingent autologous leukocyte transplantation
|
US20050239706A1
(en)
|
2003-10-31 |
2005-10-27 |
Washington University In St. Louis |
Modulation of fiaf and the gastrointestinal microbiota as a means to control energy storage in a subject
|
US7935334B2
(en)
|
2005-07-07 |
2011-05-03 |
Imagilin Technologies, LLC |
Probiotics as alternative medicines against infectious diseases
|
US20060008511A1
(en)
|
2004-07-08 |
2006-01-12 |
Jhy-Jhu Lin |
Probiotic products for pet applications
|
US7909806B2
(en)
|
2004-09-23 |
2011-03-22 |
Anthrogenesis Corporation |
Cord blood and placenta collection kit
|
EP1817432A2
(en)
|
2004-10-05 |
2007-08-15 |
Wyeth a Corporation of the State of Delaware |
Probe arrays for detecting multiple strains of different species
|
CA2586998A1
(en)
|
2004-11-08 |
2006-05-26 |
Yale University |
Structure-based compound design involving riboswitches
|
US20080075901A1
(en)
|
2005-02-23 |
2008-03-27 |
Lee S Thomas |
Multilayer Films Including Cycloolefin Copolymer and Styrene-Butadiene Copolymer
|
US20060210448A1
(en)
|
2005-03-10 |
2006-09-21 |
Naishu Wang |
Fecal specimen collection, preserving and transport device and method
|
EP2783688A1
(en)
|
2005-03-17 |
2014-10-01 |
Synhton B.V. |
Pharmaceutical tablets of crystalline type ii aripiprazole
|
US7607776B1
(en)
|
2005-10-24 |
2009-10-27 |
James Waller Lambuth Lewis |
Digital eye bank for virtual clinic trials
|
JP2009524411A
(ja)
|
2005-12-21 |
2009-07-02 |
イェール ユニバーシティー |
リボスイッチの調節に関連した方法および組成物
|
BRPI0620734A2
(pt)
|
2005-12-29 |
2012-09-18 |
Hill's Pet Nutrition, Inc |
método para melhorar o equilìbrio de bactérias benéficas e nocivas no trato gastrintestinal de um animal, uso de pelo menos um antioxidante, composição de ração, kit, e meio para comunicação de informação e/ou instruções
|
US20080008751A1
(en)
|
2006-07-10 |
2008-01-10 |
Michael Fox |
Stable formulation comprising a combination of a moisture sensitive drug and a second drug and manufacturing procedure thereof
|
US20080027353A1
(en)
|
2006-07-31 |
2008-01-31 |
Kliman Harvey J |
Method of making and using a library of biological information
|
CN101605566A
(zh)
|
2006-10-13 |
2009-12-16 |
利莱恩斯生命科学有限公司 |
生物聚合物上的培养黑素细胞
|
WO2008076696A2
(en)
|
2006-12-18 |
2008-06-26 |
Washington University In St. Louis |
The gut microbiome as a biomarker and therapeutic target for treating obesity or an obesity related disorder
|
WO2009029315A2
(en)
|
2007-05-31 |
2009-03-05 |
University Of Washington |
Inducible mutagenesis of target genes
|
EP2030623A1
(en)
|
2007-08-17 |
2009-03-04 |
Nestec S.A. |
Preventing and/or treating metabolic disorders by modulating the amount of enterobacteria
|
WO2009042645A2
(en)
|
2007-09-24 |
2009-04-02 |
President And Fellows Of Harvard College |
The use of mice predisposed to develop ulcerative colitis and colon cancer to develop metabolic profiles associated with same
|
CA2740434C
(en)
|
2007-10-26 |
2017-11-07 |
Brenda E. Moore |
Probiotic compositions and methods for inducing and supporting weight loss
|
US20090138354A1
(en)
|
2007-11-25 |
2009-05-28 |
Herbert Zech |
Methods of Storing and Providing Samples of Cells and Tissue
|
US20090148540A1
(en)
|
2007-12-10 |
2009-06-11 |
Mi Hope Incorporated |
Antibacterial composition and method of production
|
US8338812B2
(en)
|
2008-01-16 |
2012-12-25 |
Micron Technology, Inc. |
Vertical spacer electrodes for variable-resistance material memories and vertical spacer variable-resistance material memory cells
|
WO2009120347A2
(en)
|
2008-03-27 |
2009-10-01 |
Memorial Sloan Kettering Cancer Center |
Modulators of rna riboswitches
|
EP2310532B1
(en)
|
2008-06-30 |
2014-05-07 |
The Washington University |
Methods of promoting weight loss and associated arrays
|
US20100008850A1
(en)
|
2008-07-14 |
2010-01-14 |
William John Martin |
Method of generating hydrogen in drinking water using an enerceutical product added to magnesium in a hydrogen permeable but solute impermeable container
|
CN104247718A
(zh)
|
2008-07-17 |
2014-12-31 |
生物工厂公司 |
利用绿木霉物种与根际活性的哈茨木霉物种的组合来控制植物疾病与增强植物生长
|
CN102176825A
(zh)
|
2008-08-11 |
2011-09-07 |
佰欧莱利克斯公司 |
黄素衍生物
|
TW201022253A
(en)
|
2008-11-14 |
2010-06-16 |
Portola Pharm Inc |
Solid composition for controlled release of ionizable active agents with poor aqueous solubility at low pH and methods of use thereof
|
US20110240511A1
(en)
|
2008-12-10 |
2011-10-06 |
Merck Sharp & Dohme Corp. |
Packaging for oxygen-sensitive pharmaceutical products
|
BRPI1010874A8
(pt)
|
2009-05-01 |
2018-01-02 |
Ferring Bv |
composição para o tratamento de câncer de próstata
|
GB0916335D0
(en)
|
2009-09-17 |
2009-10-28 |
Martin W J |
Medicaments
|
US20120177650A1
(en)
|
2009-09-23 |
2012-07-12 |
Borody Thomas J |
Therapy for enteric infections
|
GB2548296A
(en)
|
2009-10-22 |
2017-09-13 |
Borody Thomas J |
Novel parasite therapy
|
JP2013508428A
(ja)
|
2009-10-26 |
2013-03-07 |
トーマス・ジュリアス・ボロディ |
新規な腸の併用療法
|
ES2730828T3
(es)
|
2010-02-01 |
2019-11-12 |
Rebiotix Inc |
Bacterioterapia para la colitis por Clostridium difficile
|
US8853269B2
(en)
|
2010-02-04 |
2014-10-07 |
Copperhead Chemical Company Inc. |
Composition and method for treating infections and promoting intestinal health
|
US20130005586A1
(en)
|
2010-03-01 |
2013-01-03 |
Stanislav Ehrlich |
Method of diagnostic of obesity
|
EP2542690A2
(en)
|
2010-03-01 |
2013-01-09 |
Institut National de la Recherche Agronomique |
Method of diagnostic of inflammatory bowel diseases
|
FI20105478A0
(fi)
|
2010-04-30 |
2010-04-30 |
Valtion Teknillinen |
Menetelmä tyypin 1 diabeteksen diagnosoimiseksi ja menetelmiä ja koostumuksia tyypin 1 diabeteksen puhkeamisen estämiseksi
|
US9707207B2
(en)
|
2010-05-26 |
2017-07-18 |
The United States Of America As Represented By The Department Of Veterans Affairs |
Method for diagnosing, preventing, and treating neurological diseases
|
WO2011151941A1
(ja)
|
2010-06-04 |
2011-12-08 |
国立大学法人東京大学 |
制御性t細胞の増殖または集積を誘導する作用を有する組成物
|
FI20105825A
(fi)
|
2010-07-26 |
2012-01-27 |
Suomen Punainen Risti Veripalvelu |
Veriryhmästatuksen käyttö III
|
WO2012013861A2
(en)
|
2010-07-26 |
2012-02-02 |
Suomen Punainen Risti Veripalvelu |
Use of blood group status iii
|
RU2013109251A
(ru)
|
2010-08-04 |
2014-09-10 |
Томас Джулиус БОРОДИ |
Композиции для трансплантации фекальной флоры и способы их получения и применения и устройства для их доставки
|
US9386793B2
(en)
|
2010-08-20 |
2016-07-12 |
New York University |
Compositions and methods for treating obesity and related disorders by characterizing and restoring mammalian bacterial microbiota
|
WO2012033814A2
(en)
|
2010-09-10 |
2012-03-15 |
Viropharma Incorporated |
Environmental clostridial bacteriotherapy and related formulations and methods of manufacture and use
|
WO2012050513A1
(en)
|
2010-10-11 |
2012-04-19 |
Baeckhed Fredrik |
Method for identifying a risk of cardiovascular disease by analysing oral microbiota
|
EP2680866A1
(en)
|
2011-03-01 |
2014-01-08 |
Quorum Innovations, LLC |
Materials and methods for treating conditions associated with pathogenic biofilm
|
WO2014152484A1
(en)
|
2013-03-14 |
2014-09-25 |
Regents Of The University Of Minnesota |
Freeze dried fecal microbiota for use in fecal microbial transplantation
|
WO2012122522A2
(en)
|
2011-03-09 |
2012-09-13 |
Washington University |
Cultured collection of gut microbial community
|
SG193348A1
(en)
|
2011-03-09 |
2013-10-30 |
Univ Minnesota |
Compositions and methods for transplantation of colon microbiota
|
WO2012142605A1
(en)
|
2011-04-15 |
2012-10-18 |
Samaritan Health Services |
Rapid recolonization deployment agent
|
US20120276059A1
(en)
|
2011-04-29 |
2012-11-01 |
Techlab, Inc. |
Fecal lactoferrin as a biomarker for determining disease severity and for monitoring infection in patients with clostridium difficile disease
|
WO2012159023A2
(en)
|
2011-05-19 |
2012-11-22 |
Virginia Commonwealth University |
Gut microflora as biomarkers for the prognosis of cirrhosis and brain dysfunction
|
US20130022575A1
(en)
|
2011-07-19 |
2013-01-24 |
Microbial Rx |
Systems and methods of replacing intestinal flora
|
JP2014525266A
(ja)
|
2011-08-26 |
2014-09-29 |
マイクロバイオータ ダイアグノスティクス, エルエルシー |
心欠陥を診断および治療する方法
|
US20140363397A1
(en)
|
2011-09-14 |
2014-12-11 |
Queen's University At Kingston |
Method for treatment of disorders of the gastrointestinal system
|
WO2013053836A1
(en)
|
2011-10-11 |
2013-04-18 |
Quantum Pharmaceuticals Sa |
Composition comprising anaerobically cultivated human intestinal microbiota
|
US20140360404A1
(en)
|
2011-11-09 |
2014-12-11 |
Capsugel Belgium Nv |
Acid resistant banding solution for acid resistant two piece hard capsules
|
WO2013090825A1
(en)
|
2011-12-15 |
2013-06-20 |
Pureflora, Inc. |
Device for the collection, refinement, and administration of gastrointestinal microflora
|
CN108771687A
(zh)
|
2012-02-29 |
2018-11-09 |
伊西康内外科公司 |
微生物区系的组合物及与其相关的方法
|
EP2636684A1
(en)
|
2012-03-09 |
2013-09-11 |
CSL Behring AG |
Prevention of infection
|
WO2013163582A1
(en)
|
2012-04-27 |
2013-10-31 |
Cedars-Sinai Medical Center |
Fungal mycobiome as probiotics, diagnostics and therapeutics
|
EP2850202B1
(en)
|
2012-05-18 |
2020-03-11 |
Genome Research Limited |
Methods and groups
|
JP2015522003A
(ja)
|
2012-07-02 |
2015-08-03 |
ディーエスエム アイピー アセッツ ビー.ブイ. |
チモキノンを含有するカプセル
|
US20140112985A1
(en)
|
2012-10-22 |
2014-04-24 |
Polonez Therapeutics Llc |
Method of prevention and treatment of clostridium difficile infection
|
SG11201503966PA
(en)
|
2012-11-23 |
2015-06-29 |
Seres Health Inc |
Synergistic bacterial compositions and methods of production and use thereof
|
US8906668B2
(en)
|
2012-11-23 |
2014-12-09 |
Seres Health, Inc. |
Synergistic bacterial compositions and methods of production and use thereof
|
CA2896795A1
(en)
|
2012-11-26 |
2014-05-30 |
Thomas Julius Borody |
Compositions for the restoration of a fecal microbiota and methods for making and using them
|
WO2014082132A1
(en)
|
2012-11-29 |
2014-06-05 |
Progel Pty Ltd |
Microparticles comprising a probiotic, cross-linkable reagent, a denatured protein, polyol plasticiser and trehalose
|
CA2896192C
(en)
|
2012-12-23 |
2021-01-12 |
Illuminate Consulting, Llc. |
Method and apparatus for thermally protecting and/or transporting temperature sensitive products
|
WO2014121304A1
(en)
|
2013-02-04 |
2014-08-07 |
Seres Health, Inc. |
Compositions and methods
|
EP2956006A4
(en)
|
2013-02-04 |
2017-02-22 |
Seres Therapeutics, Inc. |
Methods of populating a gastrointestinal tract
|
US9192361B2
(en)
|
2013-02-26 |
2015-11-24 |
Christopher J Stevens |
Fecal microbiome transplant material preparation method and apparatus
|
US20160040215A1
(en)
|
2013-03-14 |
2016-02-11 |
Seres Therapeutics, Inc. |
Methods for Pathogen Detection and Enrichment from Materials and Compositions
|
CA2906921A1
(en)
|
2013-03-15 |
2014-09-18 |
Seres Therapeutics, Inc. |
Network-based microbial compositions and methods
|
US9511099B2
(en)
|
2013-06-05 |
2016-12-06 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT), compositions and methods of manufacture
|
US9782445B2
(en)
|
2013-06-05 |
2017-10-10 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT), compositions and methods of manufacture
|
US9511100B2
(en)
|
2013-06-05 |
2016-12-06 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT), compositions and methods of manufacture
|
US9694039B2
(en)
|
2013-06-05 |
2017-07-04 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT), compositions and methods of manufacture
|
US10383901B2
(en)
|
2013-06-05 |
2019-08-20 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT), compositions and methods of manufacture
|
EP3375447A1
(en)
|
2013-06-05 |
2018-09-19 |
Rebiotix, Inc. |
Microbiota restoration therapy (mrt), compositions and methods of manufacture
|
US20150037285A1
(en)
|
2013-07-03 |
2015-02-05 |
New York University |
Methods for efficient transfer of viable and bioactive microbiota
|
US20160206668A1
(en)
|
2013-08-22 |
2016-07-21 |
Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno |
Production of probiotics by in vitro enrichment of beneficial microorganisms from human or animal microbiota
|
JP2015091647A
(ja)
|
2013-09-30 |
2015-05-14 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
マーキング方法、レーザー転写フィルム、インク組成物、マークが施された転写対象可食物及びその製造方法
|
CN114159476A
(zh)
|
2015-05-14 |
2022-03-11 |
克雷斯顿沃控股公司 |
用于粪便菌群移植的组合物以及用于制备和使用它们的方法和用于递送它们的装置
|
EP3297644B1
(en)
|
2015-05-22 |
2022-01-19 |
Arizona Board of Regents on behalf of Arizona State University |
Methods for treating autism spectrum disorder and associated symptoms
|
EP3303401B1
(en)
|
2015-06-01 |
2024-10-16 |
The University of Chicago |
Treatment of cancer by manipulation of commensal microflora
|
US10799539B2
(en)
|
2015-06-09 |
2020-10-13 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT) compositions and methods of manufacture
|
US10828340B2
(en)
|
2015-06-09 |
2020-11-10 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT) compositions and methods of manufacture
|
CA2986915C
(en)
|
2015-06-09 |
2023-09-19 |
Rebiotix, Inc. |
Microbiota restoration therapy (mrt) compositions and methods of manufacture
|
US10905726B2
(en)
|
2015-06-09 |
2021-02-02 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT) compositions and methods of manufacture
|
US10173160B2
(en)
|
2015-10-09 |
2019-01-08 |
Heinzen, Llc |
Effluent removal system and method of use
|
ITUB20169847A1
(it)
|
2016-01-05 |
2017-07-05 |
Wellmicro S R L |
Metodo per valutare lo stato di salute di un individuo
|
US20180000872A1
(en)
|
2016-07-01 |
2018-01-04 |
Regents Of The University Of Minnesota |
Compositions and methods for c. difficile treatment
|
EP3823652A1
(en)
|
2018-07-17 |
2021-05-26 |
Ferring BV |
Combination therapy comprising microbiota restoration therapy (mrt) compositions
|